SPM Active® for Obesity
Concentration of n-3 PUFA Monohydroxylated Derivatives in Adults With Obesity After n-3 PUFA Supplementation.
Recruiting
N/A
Interventional Study
Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 45 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 33 (estimated)
- Sponsor
- University of North Carolina, Chapel Hill · Other
Who this trial is looking for
This trial is looking for adults with obesity to see if taking SPM Active® can help improve their well-being. Participants will take two soft-gel capsules daily for 12 weeks and provide blood samples and complete surveys about their health.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 45 and 60 years old.
- I have a body mass index (BMI) between 30 and 40.
- I am any race or ethnicity.
You may not be able to join if
- I am under 45 or over 60 years old.
- I am pregnant or breastfeeding.
- I have a BMI under 30 or over 40.
- I have type 1 or type 2 diabetes.
- I have an active autoimmune disease or liver disease.
- I am allergic to fish or shellfish.
- I cannot give informed consent.
- I have cancer or am receiving treatment for cancer.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if daily supplementation with SPM Active® can increase omega 3 polyunsaturated fatty acid derivatives and improve well-being in adults with obesity. The main questions it aims to answer are:
Does 2 g/day of SPM Active® for 12 weeks increase plasma levels of 14-hydroxydocosahexaenoic (HDHA), 17-HDHA, and 18-hydroxy eicosapentaenoic acid (HEPE)?
Does 2 g…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adults, ages 45-60 years
* Body mass index (BMI) between 30 and 40 kg/m\^2
* Any race or ethnicity
Exclusion Criteria:
* Age \< 45 years or \> 60 years
* pregnant or breastfeeding women
* BMI \< 30 kg/m\^2 or \> 40 kg/m\^2
* Diagnosed type 1 or type 2 diabetes
* Active autoi…
Contacts